NYSEARCA:LABU Direxion Daily S&P Biotech Bull 3x Shares (LABU) Price, Holdings, & News $49.09 -2.81 (-5.41%) As of 09:47 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock About Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get LABU alerts:Sign Up Key Stats Today's Range$49.95▼$51.6750-Day Range$37.64▼$80.6452-Week Range$32.55▼$152.60Volume100,523 shsAverage Volume1.43 million shsMarket Capitalization$550.83 millionAssets Under Management$540.60 millionDividend Yield0.53%Net Expense Ratio0.96%Aggregate RatingModerate Buy ETF OverviewThe Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.Read More… Direxion Daily S&P Biotech Bull 3x Shares ExpensesTypeLABUHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.75%0.57%0.57%0.52%0.53%Other Expenses0.21%0.30%0.48%0.56%0.52%Total Expense0.96%0.70%0.72%0.73%0.71%Fee Waiver0.00%-0.45%-0.49%-0.65%-0.54%Net Expense0.96%0.61%0.63%0.58%0.60% Receive LABU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bull 3x Shares and its competitors with MarketBeat's FREE daily newsletter. Email Address LABU ETF News HeadlinesDirexion Daily S&P Biotech Bull 3X Shares declares quarterly distribution of $0.10714March 25, 2025 | msn.comDirexion Daily Semiconductor Bear 3X Shares rises 11.6%March 6, 2025 | markets.businessinsider.comThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?May 13, 2025 | Timothy Sykes (Ad)ULTY: ~74% Trailing Yield, But Look Out BelowOctober 11, 2024 | seekingalpha.comDirexion Daily S&P 500 Bull 3X Shares declares quarterly distribution of $0.3367September 24, 2024 | msn.comDirexion Daily S&P Biotech Bull 3X Shares declares quarterly distribution of $0.1502September 24, 2024 | msn.comSee More Headlines LABU ETF - Frequently Asked Questions How have LABU shares performed this year? Direxion Daily S&P Biotech Bull 3x Shares' stock was trading at $90.00 on January 1st, 2025. Since then, LABU stock has decreased by 42.3% and is now trading at $51.90. View the best growth stocks for 2025 here. When did Direxion Daily S&P Biotech Bull 3x Shares' stock split? Shares of Direxion Daily S&P Biotech Bull 3x Shares reverse split on the morning of Monday, December 4th 2023. The 1-20 reverse split was announced on Monday, December 4th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. Who are Direxion Daily S&P Biotech Bull 3x Shares' major shareholders? Top institutional investors of Direxion Daily S&P Biotech Bull 3x Shares include XTX Topco Ltd (0.05%), McGuire Investment Group LLC (0.04%), SBI Securities Co. Ltd. (0.03%) and Belvedere Trading LLC. How do I buy shares of Direxion Daily S&P Biotech Bull 3x Shares? Shares of LABU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Direxion Daily S&P Biotech Bull 3x Shares own? Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily S&P Biotech Bull 3x Shares investors own include Micron Technology (MU), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), AT&T (T), Direxion Daily Semiconductors Bull 3x Shares (SOXL) and Advanced Micro Devices (AMD). Fund Details IssuerDirexion Fund NameDirexion Daily S&P Biotech Bull 3x Shares Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:LABU Inception Date5/28/2015 Fund ManagerPaul Brigandi, Tony Ng WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS&P Biotechnology Select Industry Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings142 Fund Statistics Assets Under Management$479.31 million Average Daily Volume$2.37 million Discount/Premium0.06% Leveraged3.00 Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRafferty Asset Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume6,152 Put Options2,531 Call Options3,621 Short Interest1,220,000 shs Miscellaneous Outstanding Shares11,220,000Beta3.01 Creation Unit50,000 Creation Fee$250.00 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Top 10 LABU HoldingsDreyfus Govt Cash Man InsHolding Weight: 29.79%Goldman Sachs Sterling FixInc Port IncHolding Weight: 25.03%Dreyfus Trsry Securities Cash MgmtHolding Weight: 8.08%Natera (NASDAQ:NTRA)Holding Weight: 1.86%Vertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 1.79%Insmed (NASDAQ:INSM)Holding Weight: 1.78%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 1.76%Neurocrine Biosciences (NASDAQ:NBIX)Holding Weight: 1.69%United Therapeutics (NASDAQ:UTHR)Holding Weight: 1.68%Gilead Sciences (NASDAQ:GILD)Holding Weight: 1.66%Full Holdings DetailsLABU Sector ExposureLABU Industry Exposure This page (NYSEARCA:LABU) was last updated on 5/13/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.